Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is High Sensibility Troponins a Dialysable Marker in Hemodialysis Patients and Does it Have Prognostic Value?

NCT02111733 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT02111733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02111733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is High Sensibility Troponins a Dialysable Marker in Hemodialysis Patients and Does it Have Prognostic Value?
Lead sponsor
Université de Sherbrooke
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2013
Completion date
September 30, 2013
Enrollment
43 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

renal failure